Obesity Interventions – Market Insights – Europe

The European market for obesity interventions will grow through 2024, driven by increasing bariatric surgery procedure volumes—which will positively impact the unit sales of internal closure devices—and by growth in the intragastric balloon segment, because of the introduction of new products that will gain adoption.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the obesity interventions market in Europe across a 10-year period.

Most intragastric balloons continue to be implanted in patients who are willing to pay out-of-pocket for the procedure, limiting market growth.

Which countries in Europe have the highest procedure volumes and unit sales?

How will the introduction of new products impact this market?

What concerns have been expressed about swallowable balloons, such as the Obalon and the Elipse?

Several emerging devices have recently created headwinds in this market or are about to be launched.

What events have occurred and which devices have or will be impacted?

What device will likely obtain a CE mark in the near future?

What have physicians said about the POSE procedure?

 The value of the gastric band market will decline in Europe while the internal closure device market will experience growth.

How quickly is the gastric band market declining?

Which countries have the highest and lowest gastric banding procedure volumes?

What shares of the internal closure device market do Medtronic and Ethicon have in each country?

Table of contents